Loading clinical trials...

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation | Clinical Trials | Clareo Health

UNKNOWNNA

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation

NCT03177226•Virility Medical Ltd.

View on ClinicalTrials.gov

Summary

Prospective, non-randomized, controlled, single-center study, to evaluate the efficacy of applied nominal electrical stimulation parameters given to premature ejaculation (PE) patients in order to prolong the ejaculatory latency time which will eventually increase the quality of their sexual life.

Eligibility

Age

18 - 60 years

Sex

MALE

Healthy Volunteers

Inclusion Criteria

•Good general health
•Clinical history of premature ejaculation
•Familiar with self- stimulation
•Ability to follow study instructions and complete study assessment tools
•Washout period of two weeks

Exclusion Criteria

•History of cardio-vascular disorders
•Any type of implanted pacemaker/defibrillator
•Hypertension
•Diabetes Mellitus
•Local dermatological disease
•Local skin irritation/ lesions
•Any neurological disorder
•Any psychiatric disease and/or any psychiatric medications
•Any neoplastic disease in the past two years

Locations (1)

Rambam Health Care Campus

Haifa, Israel

Key Dates

Start Date

January 1, 2017

Primary Completion Date

December 1, 2017

Completion Date

December 1, 2017

Last Updated

June 6, 2017

Enrollment

ESTIMATED participants

Conditions

Premature Ejaculation

Interventions

Functional TENS stimulation

DEVICE

Non-Functional TENS stimulation

DEVICE

Contacts

Ilan Gruenwald, MD

CONTACT

+972-4-777-2819

Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)

NCT07434271

Premature Ejaculation

View study

RECRUITINGNA

Brain Activity During Sexual Behavior in Patients With Primary Premature Ejaculation a Clinical Trial

NCT06570135

Premature Ejaculation

View study

NOT_YET_RECRUITINGNA

Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 6, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation

Inclusion Criteria

Exclusion Criteria

Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)

Brain Activity During Sexual Behavior in Patients With Primary Premature Ejaculation a Clinical Trial

Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study

THE IMPACT OF VITAMIN B12 TREATMENT ON EJACULATORY FUNCTIONS IN MEN: SYMPTOMATIC RELIEF AND IMPROVED OUTCOMES

Primary Premature Ejaculation Genetics

Clinical Study to Reduce Premature Ejaculation in Healthy Adult Men